Cefoperazone

Revision as of 18:10, 7 July 2009 by Mdoherty (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

{{drugbox | IUPAC_name = (6R,7S)-7-{[2-[(4-ethyl-2,3-dioxo-piperazine-1-
carbonyl)amino]-2-(4-hydroxyphenyl)acetyl}amino]-
3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-
1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid | image = Cefoperazone.svg | CAS_number = 62893-19-0 | ATC_prefix = J01 | ATC_suffix = DD12 | ATC_supplemental = J01DD62 (WHO) | PubChem = 44185 | DrugBank = | C=25|H=27|N=9|O=8|S=2 | molecular_weight = 645.67 g/mol | bioavailability = | protein_bound = | metabolism = | elimination_half-life = | excretion = | pregnancy_AU = | pregnancy_US = | pregnancy_category= | legal_AU = | legal_CA = | legal_UK = | legal_US = | legal_status = | routes_of_administration = }} Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

WikiDoc Resources for Cefoperazone

Articles

Most recent articles on Cefoperazone

Most cited articles on Cefoperazone

Review articles on Cefoperazone

Articles on Cefoperazone in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cefoperazone

Images of Cefoperazone

Photos of Cefoperazone

Podcasts & MP3s on Cefoperazone

Videos on Cefoperazone

Evidence Based Medicine

Cochrane Collaboration on Cefoperazone

Bandolier on Cefoperazone

TRIP on Cefoperazone

Clinical Trials

Ongoing Trials on Cefoperazone at Clinical Trials.gov

Trial results on Cefoperazone

Clinical Trials on Cefoperazone at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cefoperazone

NICE Guidance on Cefoperazone

NHS PRODIGY Guidance

FDA on Cefoperazone

CDC on Cefoperazone

Books

Books on Cefoperazone

News

Cefoperazone in the news

Be alerted to news on Cefoperazone

News trends on Cefoperazone

Commentary

Blogs on Cefoperazone

Definitions

Definitions of Cefoperazone

Patient Resources / Community

Patient resources on Cefoperazone

Discussion groups on Cefoperazone

Patient Handouts on Cefoperazone

Directions to Hospitals Treating Cefoperazone

Risk calculators and risk factors for Cefoperazone

Healthcare Provider Resources

Symptoms of Cefoperazone

Causes & Risk Factors for Cefoperazone

Diagnostic studies for Cefoperazone

Treatment of Cefoperazone

Continuing Medical Education (CME)

CME Programs on Cefoperazone

International

Cefoperazone en Espanol

Cefoperazone en Francais

Business

Cefoperazone in the Marketplace

Patents on Cefoperazone

Experimental / Informatics

List of terms related to Cefoperazone

Overview

Cefoperazone is a third generation cephalosporin antibiotic. Marketed by pfizer under the name Cefobid®.

Cefina-SB is a combination of sulbactam and cefoperazone. Cefoperazone exerts its bactericidal effect by inhibiting the bacterial cell wall synthesis, and sulbactam acts as a beta-lactamase inhibitor, to increase the antibacterial activity of cefoperazone against beta-lactamase producing organisms. Cefina-SB is available as injection for the treatment of bacterial infections. In some countries, the combination is sold as Sulperazone. Cefoperazone is available in the United States as Cefobid.

Template:SIB

Template:WH Template:WS